AZD4017: Clinical Trials

4 trials of AZD4017, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4

Follow AZD4017: new trials by email Literature Review of AZD4017 trials Research Report on AZD4017

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate Methods That Assess the Effect of AZD4017 in Adipose Tissue
AZD4017, Placebo - Obesity
Phase 1CompletedAstraZeneca152010-03-012010-12-10
Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses
AZD4017, Placebo - Diabetes Mellitus Type 2
Phase 1CompletedAstraZeneca1072009-02-012009-09-30
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017.
AZD4017, Placebo - Healthy
Phase 1CompletedAstraZeneca562008-12-012009-07-02
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017
AZD4017, Placebo - Healthy
Phase 1CompletedAstraZeneca402008-11-012009-06-16

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Obesity (1)

Sponsors

AstraZeneca (4)

Countries

Sweden (3)  ·  Japan (1)

Top investigators

Marianne Hartford, MD PhD (2)  ·  Per-Anders Jansson, Ass Prof, MD, PhD (1)  ·  Shunji Matsuki (1)